Palle Christophersen (born 1958) is an ion channel physiologist and pharmacologist with more than 30 years of experience with drug discovery and development in the private industry.
Christophersen was a co-founder of Saniona in 2011 and served as CSO until 2019 and since then as Senior Vice President, Research. Prior to Saniona he was employed for 20 years in NeuroSearch, where the served in multiple managing and project leader positions for both internal and collaboration projects.
Christophersen is a biologist by training and holds a PhD in physiology and biophysics of ion channels from the University of Copenhagen. He has authored more than 65 peer-reviewed articles and is co-inventor of more the 60 patents, primarily within the ion channel field and related technology.
Christophersen holds 99,400 warrants in the warrant program 2020 and 740,000 shares.